16 | Irinotecan (Camptosar)FDA LinkGeneric
04/2012
-
02/2004 |
8 | 1-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2023
-
01/2018 |
8 | selenomethylselenocysteine (methylselenocysteine)IBA
10/2018
-
07/2004 |
7 | SeleniumIBA
10/2018
-
04/2004 |
5 | Photosensitizing Agents (Photosensitizers)IBA
12/2023
-
01/2018 |
4 | 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH)IBA
08/2022
-
01/2018 |
3 | Chlorophyll AIBA
04/2023
-
01/2022 |
3 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2012
-
12/2004 |
3 | Fluorouracil (Carac)FDA LinkGeneric
01/2005
-
02/2004 |
2 | Reactive Oxygen Species (Oxygen Radicals)IBA
06/2023
-
01/2010 |
2 | pyropheophorbide aIBA
08/2022
-
12/2020 |
2 | Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2021
-
01/2019 |
2 | LipidsIBA
10/2018
-
10/2018 |
2 | Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
10/2018
-
07/2012 |
2 | Proteins (Proteins, Gene)FDA Link
01/2010
-
02/2005 |
2 | Carbonic Anhydrase IXIBA
08/2008
-
12/2004 |
2 | Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2006
-
01/2005 |
2 | raltitrexed (D 1694)IBA
04/2006
-
01/2005 |
1 | Bacteriochlorophyll AIBA
12/2023 |
1 | Retinaldehyde (Retinal)IBA
12/2023 |
1 | Oxygen (Dioxygen)IBA
06/2023 |
1 | Dihematoporphyrin Ether (Porfimer Sodium)FDA Link
06/2023 |
1 | Galectin 1 (LGALS1)IBA
06/2023 |
1 | Galectin 3 (LGALS3)IBA
06/2023 |
1 | EstersIBA
04/2023 |
1 | Carboxylic AcidsIBA
04/2023 |
1 | AcidsIBA
08/2022 |
1 | pheophorbide aIBA
08/2022 |
1 | CarbohydratesIBA
08/2022 |
1 | Galactose (Galactopyranose)FDA LinkGeneric
08/2022 |
1 | Doxorubicin (Adriamycin)FDA LinkGeneric
04/2022 |
1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2022 |
1 | polyacrylamideIBA
12/2020 |
1 | Singlet OxygenIBA
12/2020 |
1 | IonsIBA
12/2020 |
1 | Pentetic Acid (DTPA)FDA LinkGeneric
12/2020 |
1 | ErbB Receptors (EGF Receptor)IBA
01/2019 |
1 | Biomarkers (Surrogate Marker)IBA
10/2018 |
1 | Thymidine PhosphorylaseIBA
10/2018 |
1 | Drug CombinationsIBA
10/2018 |
1 | Methionine (L-Methionine)FDA Link
10/2018 |
1 | MicroRNAs (MicroRNA)IBA
10/2018 |
1 | Hypoxia-Inducible Factor 1IBA
07/2012 |
1 | Selenium CompoundsIBA
04/2012 |
1 | Topoisomerase I InhibitorsIBA
06/2011 |
1 | Angiogenesis InhibitorsIBA
06/2011 |
1 | Bevacizumab (Avastin)FDA Link
06/2011 |
1 | Small Interfering RNA (siRNA)IBA
10/2010 |
1 | methylselenic acidIBA
10/2010 |
1 | Antineoplastic Agents (Antineoplastics)IBA
01/2010 |
1 | Cystine (L-Cystine)IBA
01/2010 |
1 | Tirapazamine (SR 4233)IBA
08/2008 |
1 | Cyclooxygenase 2 (Cyclooxygenase-2)IBA
02/2007 |
1 | Celecoxib (Celebrex)FDA Link
02/2007 |
1 | DNA Repair EnzymesIBA
05/2005 |
1 | Fas Ligand Protein (Fas Ligand)IBA
05/2005 |
1 | Cytochrome P-450 CYP3AIBA
05/2005 |
1 | 6- (3- (2- hydroxyethyl)amino- 1- propyl)- 5,6- dihydro- 2,3- dimethoxy- 8,9- methylenedioxy- 5,11- dioxo- 11H- indeno(1,2- )isoquinolineIBA
02/2005 |
1 | Capecitabine (Xeloda)FDA Link
01/2005 |
1 | Differentiation AntigensIBA
12/2004 |
1 | involucrinIBA
12/2004 |
1 | pimonidazoleIBA
12/2004 |
1 | L-methionine gamma-lyaseIBA
07/2004 |
1 | Type I DNA Topoisomerases (Topoisomerase I)IBA
04/2004 |
1 | PoisonsIBA
04/2004 |